Como Citar
1.
Becx-Bleumínk M. Epidemiologia da Reação. Hansen. Int. [Internet]. 30º de junho de 1998 [citado 28º de dezembro de 2024];23(Especial):59-66. Disponível em: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35926
Resumo
.
Referências
BECX-BLEUMINK M. Operational aspects of multidrug therapy. Int. J. Lepr, 1989;57:540-551.
BECX-BLEUMINK M, Berhe D, 't Mannetje W. The management of nerve damage in the leprosy control services. Lepr. Rev, 1990;61:1-11.
BECX-BLEUMINK M, Berhe D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy, Experience in the leprosy control programme of the All Africa Leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia. Int. J. Lepr, 1992;60:173-184.
BOERRIGTER G, Ponnighaus J.M., Fine P.E.M. Preliminary appraisal of a WHO-recommended multi-drug therapy regimen in paucibacillary leprosy patients in Malawi.) Int. J. Lepr, 1988;56:408-417.
BOERRIGTER G, Ponninhaus JM, Fine P.E.M., Wilson RJ. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. Int. J. Lepr,1981;59:255-261.
VAN BRAKEL W. Peripheral Neuropathy in leprosy, the continuing clallenge. PhD thesis, Utrecht, The Netherlands, 1994.
GROENEN G, Janssens L., Kayembe T., Nollet E., Coussens L., Pattyn S.R. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Int. J. Lepr, 1986;54:236-244.
HASTINGS RC (Ed) Leprosy 1985; Churchill Livingstone, Edinburgh.
KATOCH K, Ramanathan U, Natrajan M, Bagga A.K., Nhatia A.S., Saxana R.K., Ramu G. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampicin int. J. Lepr, 1989; 57:458-464.
LIENHARDT C., Fine P.E.M. Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev, 1994;65:9-33.
- LOCKWOOD D.J., Vinayakumar S., Stanley J.N.A., McAdam K.P.W.J., Colston MJ. Clinical features and outcome of reversal (Type 1) reactions in Hyderabad, India. Int. J. Lepr. 1993;61:8-15.
- de RIJK A.J., Gabre S., Byass P., Berhanu T. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project-II. Reaction and neuritis during and after MDT in PB and MB leprosy patients. Lepr. Rev,
1994;65:320-332.
BECX-BLEUMINK M, Berhe D, 't Mannetje W. The management of nerve damage in the leprosy control services. Lepr. Rev, 1990;61:1-11.
BECX-BLEUMINK M, Berhe D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy, Experience in the leprosy control programme of the All Africa Leprosy and Rehabilitation Training Centre (ALERT) in Ethiopia. Int. J. Lepr, 1992;60:173-184.
BOERRIGTER G, Ponnighaus J.M., Fine P.E.M. Preliminary appraisal of a WHO-recommended multi-drug therapy regimen in paucibacillary leprosy patients in Malawi.) Int. J. Lepr, 1988;56:408-417.
BOERRIGTER G, Ponninhaus JM, Fine P.E.M., Wilson RJ. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. Int. J. Lepr,1981;59:255-261.
VAN BRAKEL W. Peripheral Neuropathy in leprosy, the continuing clallenge. PhD thesis, Utrecht, The Netherlands, 1994.
GROENEN G, Janssens L., Kayembe T., Nollet E., Coussens L., Pattyn S.R. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions. Int. J. Lepr, 1986;54:236-244.
HASTINGS RC (Ed) Leprosy 1985; Churchill Livingstone, Edinburgh.
KATOCH K, Ramanathan U, Natrajan M, Bagga A.K., Nhatia A.S., Saxana R.K., Ramu G. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampicin int. J. Lepr, 1989; 57:458-464.
LIENHARDT C., Fine P.E.M. Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev, 1994;65:9-33.
- LOCKWOOD D.J., Vinayakumar S., Stanley J.N.A., McAdam K.P.W.J., Colston MJ. Clinical features and outcome of reversal (Type 1) reactions in Hyderabad, India. Int. J. Lepr. 1993;61:8-15.
- de RIJK A.J., Gabre S., Byass P., Berhanu T. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project-II. Reaction and neuritis during and after MDT in PB and MB leprosy patients. Lepr. Rev,
1994;65:320-332.
Este periódico está licenciado sob uma Creative Commons Attribution 4.0 International License.
Downloads
Não há dados estatísticos.
